4basebio AG: Capital reduction at a rate of 9:1

With value date 3 March 2021, a capital reduction of 4basebio AG registered shares (ISIN DE000A2YN801) at a ratio of 9:1 into converted 4basebio AG registered shares (ISIN DE000A3H3L44) takes place. 

The corresponding processing steps and their chronological sequence are described below.

Re-registration stop

From 26 February 2021 to 3 March 2021, the registration and transmission of re-registrations or initial registrations in 4basebio AG registered shares (ISIN DE000A11QW50) in CASCADE-RS is not possible. During this period, the system will automatically delete re-registration or initial registration instructions that are pending in CASCADE-RS.

The registration and transmission of instructions for re-registration and initial registration is possible starting 3 March 2021 for converted 4basebio AG registered shares (ISIN DE000A3H3L44).

Removal of holdings

On 2 March 2021 and in preparation for the removal, Clearstream Banking AG¹ will automatically transfer the registered positions in 4basebio AG registered shares to the unregistered positions of the respective bank via de-registration.

With a value date of 3 March 2021, the holdings in 4basebio AG registered shares (ISIN DE000A2YN801) will be removed from the banks.

Entry of fractional rights

At value date 3 March 2021, 4basebio AG fractional rights (ISIN DE000A3H3LP3) will be transferred to the banks at a rate of 9:1. This means that for nine 4basebio AG registered shares (ISIN DE000A2YN801) the banks receive one 4basebio AG fractional right (ISIN DE000A3H3LP3).

Exchange of fractional rights into original shares

From 3 March 2021 to 15 March 2021 inclusive customers can exchange 4basebio AG fractional rights (ISIN DE000A3H3LP3) into converted shares of 4basebio AG (ISIN DE000A3H3L44). For this purpose, please use the transaction KVEE WE (securities transfer) with the fractional rights indicator TR 3 in CASCADE:

Stock exchange trades, CCP and OTC transactions

Stock exchange and CCP transactions that are still pending on the evening of 2 March 2021 will be converted automatically, that is, 4basebio AG registered shares (ISIN DE000A2YN801) shares are converted to 4basebio AG fractional rights (ISIN DE000A3H3LP3) and the nominal value is adjusted at a rate of 8:1.

CASCADE-OTC transactions will not be converted automatically.

Registration of shareholders via re-registration

After the capital reduction, the custodian banks must enter the shareholders of 4basebio AG converted registered shares (ISIN DE000A3H3L44) in the company's share register via re-registration. This will be possible starting from 3 March 2021. The nominal value after the capital reduction must be used.

Note for LIMA users

Due to the processing capacities in CASCADE-RS, submissions amounting to 10,000 re-registrations or more per transfer must be agreed in advance with Client Services. CBF reserves the right to reject file transfers that have not been agreed upon within the scope of overall coordination.

------------------------------

1. This announcement is published by Clearstream Banking AG (CBF), registered office at Mergenthalerallee 61, 65760 Eschborn, Germany, registered with the Commercial Register of the District Court in Frankfurt am Main, Germany, under number HRB 7500.